Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review

被引：0
|
作者：
Chia-Chen Tsai
Sophia Jette
Helen Tremlett
机构：
[1] University of British Columbia,Division of Neurology, Faculty of Medicine, Djavad Mowafaghian Centre for Brain Health, Room S126, 2211 Wesbrook Mall
[2] University of British Columbia,Faculty of Medicine
来源：
Journal of Neurology | 2024年 / 271卷
关键词：
Multiple sclerosis; Disease-modifying therapy; Gut microbiome; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1108 / 1123
页数：15
相关论文
共 50 条
  • [41] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [42] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [43] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [44] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [45] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
  • [46] The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
    Shahtaheri, Rahil Sadat
    Nikfar, Shekoufeh
    Khorasani, Elahe
    Sabbagh-Baniazad, Mansoureh
    Goudarzi, Zahra
    Emamikhah, Maziar
    CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (03): : 138 - 145
  • [47] Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis
    Sriwastava, Shitiz
    Kataria, Saurabh
    Srivastava, Samiksha
    Kazemlou, Shaghayegh
    Gao, Si
    Wen, Sijin
    Saber, Hamidreza
    Tripathi, Richa
    Sheikh, Zubeda
    Peterson, Sarah
    Gwinn, Ronald
    Bernitsas, Evanthia
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [48] Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: A systematic review
    Dantas, Luiza Andraus
    Pereira, Marina Steingraber
    Gauza, Amanda de Miranda
    Bonetti Schulz, Maria Eduarda
    da Silva, Gustavo Figueiredo
    Marchi Martin, Maria Eduarda
    Gomes de Medeiros Junior, Washigton Luiz
    Magno Goncalves, Marcus Vinicius
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [49] EFFICACY AND SAFETY OF DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW
    Lingohr-Smith, M.
    Deitelzweig, C.
    Lin, G.
    Lin, J.
    VALUE IN HEALTH, 2021, 24 : S158 - S158
  • [50] Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies
    Amezcua, Lilyana
    Morrow, Mark J.
    Jirawuthiworavong, Guy V.
    CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (06) : 534 - 539
12345